Category:Unknown-importance pharmacology articles
 | Administrators: Please do not delete this category as empty! This category may be empty occasionally or even most of the time. |
| Top | High | Mid | Low | NA | ??? |
| 120 | 881 | 3,128 | 6,569 | 2,449 | 3,484 |
Pages in category "Unknown-importance pharmacology articles"
The following 200 pages are in this category, out of approximately 3,484 total. This list may not reflect recent changes.
(previous page) (next page)M
- Talk:Mocetinostat
- Talk:Mochida Pharmaceutical
- Talk:Modotuximab
- Talk:Mofebutazone
- Talk:Mofezolac
- Talk:Molecular glue
- Talk:Molecular modification
- Talk:Molecule-based magnets
- Talk:Monalizumab
- Talk:Monatepil
- Talk:Monepantel
- Talk:Monkey Drug Trials
- Talk:Monoamine neurotoxin
- Talk:Monoaminergic activity enhancer
- Talk:Monoctanoin
- Talk:Monoethanolamine oleate
- Talk:Monometacrine
- Talk:Monomethyl auristatin
- Talk:Morantel
- Talk:Morniflumate
- Talk:Morning pseudoneutropenia
- Talk:Morolimumab
- Talk:Morpheridine
- Talk:Morphine/naltrexone
- Talk:Morris water navigation task
- Talk:Mosapramine
- Talk:Motexafin gadolinium
- Talk:Moxaverine
- Talk:Moxisylyte
- Talk:Moxonidine
- Talk:Mozenavir
- Talk:MPP+
- Talk:MRI contrast agent
- Talk:MRK-409
- Talk:MRZ-9547
- Talk:MS-377
- Talk:MS1 (drug)
- Talk:MSP-1014
- Talk:MSX-2
- Talk:MSX-4
- Talk:MT-7716
- Talk:Muzafer Mujić
- Talk:Multistate Pharmacy Jurisprudence Examination
- Talk:Muraglitazar
- Talk:Muskroot
- Talk:MVA85A
- Talk:MYCO-005
- Talk:Myostatin inhibitor
- Talk:Myristicin
- Talk:Myrophine
- Talk:Myrtecaine
N
- Talk:N of 1 trial
- Talk:N-Acetyl-γ-aminobutyraldehyde
- Talk:N-Acetyl-γ-aminobutyric acid
- Talk:N-Acetylputrescine
- Talk:N-Desmethylenzalutamide
- Talk:N-Ethyl-2C-B
- Talk:N-Methylamisulpride
- Talk:N-Methylspiperone
- Talk:N-Phenethyl-14-ethoxymetopon
- Talk:N-Terminal domain antiandrogen
- Talk:N1-Methyl-lysergic acid diethylamide
- Talk:Nabilone
- Talk:Nacolomab tafenatox
- Talk:Nadroparin calcium
- Talk:Nafamostat
- Talk:Nafimidone
- Talk:Naftifine
- Talk:Naftopidil
- Talk:Nagai Nagayoshi
- Talk:Osamu Nagayama
- Talk:Mohan D. Nair
- Talk:Naldecon
- Talk:NAMI-A
- Talk:Namilumab
- Talk:Nanocell
- Talk:NanoCLAMP
- Talk:Naphazoline
- Talk:NAPLEX
- Talk:Naptumomab estafenatox
- Talk:Naratriptan
- Talk:Narlaprevir
- Talk:Narnatumab
- Talk:NAS-181
- Talk:Nasal vaccine
- Talk:National Council for Prescription Drug Programs
- Talk:Nature Reviews Drug Discovery
- Talk:Naunyn-Schmiedeberg's Archives of Pharmacology
- Talk:Navacaprant
- Talk:Navafenterol
- Talk:NBI-1076968
- Talk:NBI-1117568
- Talk:Nealbarbital
- Talk:Nebacumab
- Talk:Nebracetam
- Talk:Nederlandsche Cocaïnefabriek
- Talk:Nedocromil
- Talk:Nefiracetam
- Talk:Nemtabrutinib
- Talk:Neramexane
- Talk:Nerelimomab
- Talk:Nesiritide
- Talk:NESS-0327
- Talk:Nesvacumab
- Talk:Neuraminidase inhibitor
- Talk:NeuroAiD
- Talk:Neuroleptanalgesic
- Talk:Neuromuscular drug
- Talk:Neurotrophin mimetics
- Talk:Newhouse Research Site
- Talk:NHS treatments blacklist
- Talk:Niacin/lovastatin
- Talk:Niacin/simvastatin
- Talk:Niceritrol
- Talk:Niclosamide
- Talk:Nicofuranose
- Talk:Nicomide
- Talk:Nicotiana rustica
- Talk:Nicotinic antagonist
- Talk:Nicotinyl alcohol
- Talk:NicVAX
- Talk:Nifenazone
- Talk:Nifene
- Talk:Nifurzide
- Talk:Nihon Pharmaceutical University
- Talk:Nikethamide
- Talk:Nilvadipine
- Talk:Nimotuzumab
- Talk:Nimustine
- Talk:Nipocalimab
- Talk:NITD008
- Talk:Nitrendipine
- Talk:Nitrofurazone
- Talk:Nitroxoline
- Talk:NL-201
- Talk:NMDA receptor modulator
- Talk:NNC 63-0532
- Talk:Non steroidal aromatase inhibitors
- Talk:NONMEM
- Talk:Nonsteroidal estrogen
- Talk:Norbuprenorphine
- Talk:Norcocaine
- Talk:Norgesic
- Talk:North China Pharmaceutical Group
- Talk:North-methanocarbathymidine
- Talk:Norwegian Pharmacy Association
- Talk:Noscapine
- Talk:Novasep
- Talk:NovoBiotic Pharmaceuticals
- Talk:NPS-2143
- Talk:NS-136
- Talk:NS-2664
- Talk:NS-2710
- Talk:Nucleic acid inhibitor
- Talk:Nutrient enema
O
- Talk:O,O′-Diacetyldopamine
- Talk:O,O′-Dipivaloyldopamine
- Talk:Obetrol
- Talk:Obexelimab
- Talk:Obinutuzumab
- Talk:Oblimersen
- Talk:Ocaratuzumab
- Talk:Ocedurenone
- Talk:Ocinaplon
- Talk:Octodrine
- Talk:Odalasvir
- Talk:Odanacatib
- Talk:Odapipam
- Talk:Odilorhabdin
- Talk:ODMA (drug)
- Talk:Odulimomab
- Talk:Peter Oehme
- Talk:Off-target activity
- Talk:Officina Profumo-Farmaceutica di Santa Maria Novella
- Talk:Ofranergene obadenovec
- Talk:Akira Ogata
- Talk:Olamkicept
- Talk:Morẹ́nikẹ́ Ọláòṣebìkan
- Talk:Olcegepant
- Talk:Oleclumab
- Talk:Oleoyl-estrone
- Talk:Oleoylethanolamide
- Talk:Oligodynamic effect
- Talk:Olmutinib
- Talk:Olodaterol
- Talk:Olokizumab
- Talk:Olorofim
- Talk:Olpasiran
- Talk:Omacetaxine mepesuccinate
- Talk:Omapatrilat
- Talk:Omarigliptin
- Talk:Shamil Omarov
- Talk:Ombitasvir
- Talk:Omigapil
- Talk:Omoconazole
- Talk:On Immunity
- Talk:Onartuzumab
- Talk:Oncology Drug Advisory Committee
- Talk:Oneirogen
- Talk:Online pharmacy laws in India